Bavarian Nordic, Inc.

Durham, NC Part of Bavarian Nordic A / S

UEI
LA6TFGKSSFC1
CAGE
7V2J4
Primary NAICS
325414 Biological Product (except Diagnostic) Manufacturing
SAM.gov registration
Active through

Company facts

FY2025 rankings

Its parent company, Bavarian Nordic A / S, ranks:

and 1 more

Self-certified in SAM.gov
  • Foreign Owned
  • For Profit Organization
Entity structure
Corporate Entity (Not Tax Exempt)
Corporate family
SAM.gov registration date
Physical address
1005 Slater Rd STE 101, Durham, NC 27703, USA
Founded
1994
Employees
1K-5K
Estimated annual revenue
$250M-$500M
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Pharmaceuticals
SIC code
28 Chemical & Allied Products

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Contract obligations by fiscal year

Fiscal year Obligated
FY2027 To date $0
FY2026 $0
FY2025 $0
FY2024 $0
FY2023 $25,740

Contract vehicles

Contract awards

Award Agency Obligated Awarded
Rabies vaccine 2.5UNT/VIL INJ, kit rabavert (PF) 75D30123F17839 CDC Pittsburgh $25,740

Similar vendors

About the company

Bavarian Nordic, Inc. is a biotechnology company focused on the development and manufacturing of cancer immunotherapies and vaccines for infectious diseases. The company provides pharmaceuticals and vaccines to federal agencies through various contract vehicles.

Bavarian Nordic has provided rabies vaccines to the Centers for Disease Control and Prevention and the Department of Agriculture through delivery orders and blanket purchase agreements issued against the company's Federal Supply Schedule contract for Pharmaceuticals and Drugs. A $25,740 firm fixed price delivery order was recently awarded by the CDC to provide 2.5 unit/dose vials of the Rabavert rabies vaccine by October 2023. Additionally, the Department of Agriculture's Animal and Plant Health Inspection Service awarded a $250,000 blanket purchase agreement to procure rabies vaccines under Federal Supply Schedule 61-IB to support disease prevention and control efforts.

Bavarian Nordic holds multiple Federal Supply Schedule contracts which allow federal agencies to efficiently procure pharmaceuticals, drugs, and vaccines on an as-needed basis. The company was awarded a 5-year $10 million schedule by the Department of Veterans Affairs in 2020 for drugs, pharmaceuticals, and hematology-related products. Bavarian Nordic also holds a separate pharmaceuticals schedule contract with a $25,000 potential value originally awarded in 2020. Task orders under these schedules have been utilized by the CDC and Department of Agriculture to procure rabies vaccines in support of public health and animal health missions related to rabies exposure risk reduction.

Quick answers

Is Bavarian Nordic, Inc. registered in SAM.gov?

Yes. Bavarian Nordic, Inc.'s SAM.gov registration is active through March 2, 2027.

Which contract vehicles does Bavarian Nordic, Inc. hold?

Bavarian Nordic, Inc. holds a place on 1 federal contract vehicle: FSS-61-IB.

How much has Bavarian Nordic, Inc. received in federal contracts?

Federal contracts obligated $25,740 to Bavarian Nordic, Inc. in fiscal years 2023 through 2027.

How does Bavarian Nordic, Inc. rank among federal contractors?

Bavarian Nordic, Inc.'s parent company, Bavarian Nordic A / S, ranked #3 in NAICS 325412, #5 in NAICS 3254 and #5 in PSC 6505 in FY2025.

What is Bavarian Nordic, Inc.'s most recent federal award?

Bavarian Nordic, Inc.'s most recent federal contract award is Rabies vaccine 2.5UNT/VIL INJ, kit rabavert (PF) (75D30123F17839), from CDC Pittsburgh, on September 13, 2023.

On GovTribe

See Bavarian Nordic, Inc.'s full federal record

  • Federal contract awards
  • IDV awards
  • Contract vehicles
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors